Phase Ib, open-label, fixed-sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine

Andrew M. Blumenfeld, Ramesh Boinpally, Rosa De Abreu Ferreira, Joel M. Trugman, Brett Dabruzzo, Jessica Ailani, Richard B. Lipton

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Phase Ib, open-label, fixed-sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine'. Together they form a unique fingerprint.

Medicine & Life Sciences